Association of ERCC1 (rs11615) and DNASE2B (rs3738573) polymorphisms with pathologic complete response to neoadjuvant chemotherapy for HER2-overexpressing breast cancer.

Agnès Ducoulombier,Aurélie Dumont,Emmanuelle Tresch,Jinying Chen,Diane Pannier,Françoise Révillion,Jacques Bonneterre,Jean-Philippe Peyrat

Association of ERCC1 (rs11615) and DNASE2B (rs3738573) polymorphisms with pathologic complete response to neoadjuvant chemotherapy for HER2-overexpressing breast cancer.

2017

Agnès Ducoulombier
Aurélie Dumont
Emmanuelle Tresch
Jinying Chen
Diane Pannier
Françoise Révillion
Jacques Bonneterre
Jean-Philippe Peyrat

536 Background: Pathological complete response (pCR) is the main prognostic factor after preoperative chemotherapy. Predictive factors of pCR are mainly histological type, hormonal status, HER2 ove...

Keywords:

Internal medicine
Pathological
Oncology
ERCC1
Breast cancer
Pathology
Hormone
Chemotherapy
Medicine
preoperative chemotherapy
prognostic factor
histological type
complete response

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations